Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

FHS
July 6, 2023
10:56 am

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

Medicare details the structure of its new drug price negotiation program

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to

June 30, 2023

Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had

June 29, 2023

Pharmalittle: We’re reading about a cancer therapy’s gold rush, FDA warning Sanofi, and more news

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.